+919405117673
Tenofovir + Lamivudine + Efavirenz Tablets: Mechanism of Action, Uses & Global Export by Cordium
As the global demand for high-quality HIV antiretroviral therapy (ART) continues to grow, Tenofovir + Lamivudine + Efavirenz Tablets (TLE) remain an important treatment option in many healthcare programs, particularly where efavirenz-based regimens are still in use. While current WHO guidelines generally prefer dolutegravir-based regimens, TLE continues to be used in specific clinical settings and national treatment programs.

Mechanism of Action (MOA)

Tenofovir Disoproxil Fumarate (TDF)

A Nucleotide Reverse Transcriptase Inhibitor (NtRTI).
Blocks HIV reverse transcriptase, preventing viral DNA synthesis and reducing HIV replication.

Lamivudine (3TC)

A Nucleoside Reverse Transcriptase Inhibitor (NRTI).
Inhibits reverse transcriptase, stopping HIV from multiplying inside human immune cells.

Efavirenz (EFV)

A Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI).
Directly binds to HIV-1 reverse transcriptase, altering the enzyme's function and preventing viral replication.
Combined Effect

The triple-drug combination:

Suppresses HIV viral load
Helps increase CD4 cell count
Reduces the risk of HIV progression to AIDS
Improves long-term treatment outcomes when taken consistently under medical supervision.
Uses of Tenofovir + Lamivudine + Efavirenz Tablets
HIV-1 infection treatment
Combination Antiretroviral Therapy (ART)
Long-term viral suppression
Prevention of HIV disease progression
Used in selected national HIV treatment programs where efavirenz-based regimens remain indicated

Note: Current WHO recommendations generally favor dolutegravir-based regimens for most newly initiated patients, although efavirenz-containing regimens continue to have roles in certain settings.

Global Export Markets

Cordium Pharmaceuticals Pvt. Ltd. supplies quality-assured Tenofovir + Lamivudine + Efavirenz Tablets to international pharmaceutical buyers, government tenders, NGOs, hospitals, and distributors across:

πŸ‡°πŸ‡ͺ Kenya
πŸ‡³πŸ‡¬ Nigeria
πŸ‡¬πŸ‡­ Ghana
πŸ‡΅πŸ‡­ Philippines
πŸ‡»πŸ‡³ Vietnam
πŸ‡¦πŸ‡ͺ UAE
πŸ‡ΈπŸ‡¦ Saudi Arabia
πŸ‡ΊπŸ‡Ώ Uzbekistan
πŸ‡°πŸ‡Ώ Kazakhstan
πŸ‡ΊπŸ‡Έ USA
πŸ‡¬πŸ‡§ UK
πŸ‡ΏπŸ‡¦ South Africa

Why Choose Cordium Pharmaceuticals Pvt. Ltd.?

βœ” WHO-GMP Manufacturing Standards
βœ” International Export Documentation
βœ” Bulk Supply & Third-Party Manufacturing
βœ” Competitive Global Pricing
βœ” Reliable Pharmaceutical Export Partner
βœ” Regulatory Support for International Markets
Jun 26th, 2026 3:17 PM

Keywords